OMI

Multiplex Flow Immunoassay, T. Gondii, Rubella And Cmv

Product code
OMI
Device name
Multiplex Flow Immunoassay, T. Gondii, Rubella And Cmv
Device class
Class 2
21 CFR
21 CFR 866.3510
Medical specialty
Microbiology
Marketing pathway
510(K)
510(k) clearances (all years, FDA)
2 (all years; only the last 3 years are listed here)

FDA classification definition

The kit is a multiplex immunoassay intended for the quantitative detection of IgG antibodies to Toxoplasma gondii (T. gondii) and Rubella, and qualitative detection of Cytomegalovirus (CMV) IgG in human serum and/ or plasma. Indicated as an aid in the determination of serological status to T. gondii, Rubella and CMV. This kit is not intended for use in screening blood or plasma donors.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

Official FDA classification page: OMI
Classification and pathway per current FDA publications. Data from openFDA (CC0).